Literature DB >> 17143598

Correlation between Yersinia enterocolitica and type I collagen reactivity in patients with arthropathies.

María G Lacoste1, Héctor Tamashiro, Silvia G Correa, Ana M S de Guzmán, María S Di Genaro.   

Abstract

We investigated the association with Yersinia infection in patients with arthropathies in our region. To assess the reactivity to articular antigens, the correlation of anti-Yersinia with anti-type I and type II collagen antibodies was studied. Sera from 124 patients with musculoskeletal symptoms, and 47 synovial fluids (SF) from patients with rheumatoid arthritis (RA), spondyloarthopathies (SpA) or osteoarthritis (OA) were examined. Immunoglobulins against Yersinia enterocolitica, type I and type II collagens were determined by enzyme-linked immunosorbent assay. Immunoglobulin (Ig) A to Yersinia lipopolysaccharide (LPS) was present in 13/124 sera (10%) and 3/47 SF (6%). By Western blot, IgA to Yersinia outer proteins (Yops) was found in 14/124 sera (11%) and 2/47 SF (4%). Yersinia DNA from SF was not amplified by polymerase chain reaction. We found a significant correlation with anti-collagen type I but not type II antibodies. These results suggest different reactivity to articular collagen in patients with Yersinia antibodies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143598     DOI: 10.1007/s00296-006-0274-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  42 in total

Review 1.  Reactive arthritis or chronic infectious arthritis?

Authors:  J Sibilia; F-X Limbach
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

2.  Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Yersinia-triggered reactive arthritis.

Authors:  A M Viitanen; T P Arstila; R Lahesmaa; K Granfors; M Skurnik; P Toivanen
Journal:  Arthritis Rheum       Date:  1991-01

Review 3.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

4.  Serological diagnosis of yersiniosis by immunoblot technique using virulence-associated antigen of enteropathogenic Yersiniae.

Authors:  J Heesemann; C Eggers; J Schröder
Journal:  Contrib Microbiol Immunol       Date:  1987

5.  Is undifferentiated seronegative spondyloarthropathy a forme fruste of reactive arthritis?

Authors:  A Aggarwal; R Misra; S Chandrasekhar; K N Prasad; R Dayal; A Ayyagari
Journal:  Br J Rheumatol       Date:  1997-09

6.  [The role of Salmonella and Yersinia in the pathogenesis of spondyloarthropathies and rheumatoid arthritis. I. Detection of bacteria, bacterial DNA, lipopolysaccharide and ECA antigen in synovial fluid or blood].

Authors:  Waldemar Rastawicki; Marek Jagielski; Rafał Gierczyński; Halina Garwolińska; Brygida Kwiatkowska; Anna Filipowicz-Sosnowska
Journal:  Med Dosw Mikrobiol       Date:  2005

7.  Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies.

Authors:  C Pacheco-Tena; C Alvarado De La Barrera; Y López-Vidal; J Vázquez-Mellado; Y Richaud-Patin; R I Amieva; L Llorente; A Martínez; J Zúñiga; M Cifuentes-Alvarado; R Burgos-Vargas
Journal:  Rheumatology (Oxford)       Date:  2001-08       Impact factor: 7.580

8.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

9.  Yersinia lipopolysaccharide is modified by human monocytes.

Authors:  M Wuorela; S Jalkanen; P Toivanen; K Granfors
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  Plasmids of human strains of Yersinia enterocolitica: molecular relatedness and possible importance for pathogenesis.

Authors:  J Heesemann; C Keller; R Morawa; N Schmidt; H J Siemens; R Laufs
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.